Friday, June 19, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home AI & Quantum Computing

Cerebras Races Into First Earnings Report After Back-to-Back Double-Digit Gains

SiterGedge by SiterGedge
June 19, 2026
in AI & Quantum Computing, Earnings, Nasdaq, Semiconductors
0
CEREBRAS SYSTEMS INC - A Stock
0
SHARES
4
VIEWS
Share on FacebookShare on Twitter

Cerebras Systems is heading into its maiden quarterly report as a public company with a burst of momentum that has recouped much of the sharp pullback from its all-time high. The AI chipmaker’s shares climbed roughly 10% on Wednesday to close near $235, then followed up with a 13% surge on Thursday that lifted the stock to an intraday high of $241 before settling. The two-day rebound erased a string of losses that had dragged the equity down to around $202, though Thursday’s rally came on thin volume — just 2.8 million shares traded against a five-day average of 5.19 million, suggesting positioning ahead of the numbers rather than broad-based buying.

The market is counting down to June 23, when Cerebras will publish results for the first quarter of fiscal 2026 after the US close. It is the first hard test since the May IPO, and management must convince investors the blistering growth trajectory is sustainable. The stock has already swung wildly — the 52-week range spans $185 to $386 — and the earnings print will determine whether the recent recovery has legs or fades into another leg lower.

Wall Street Unanimous — But Beware the Valuation Gap

Every major analyst who has initiated coverage since the IPO lockup expired is bullish. Citi, Morgan Stanley, Wedbush, Rosenblatt, Needham, Mizuho, Barclays, TD Cowen and UBS all issued buy ratings, and Craig-Hallum later joined with a $325 target. The consensus price target stands at $294, while Citi’s $340 is the Street high. Morgan Stanley calls Cerebras “one of the most differentiated AI infrastructure companies” and expects revenue to hit roughly $6 billion by 2028.

Yet the stock traded 27% below that consensus target even after Thursday’s jump, and the price-to-earnings ratio remains above 523. The disconnect between analyst euphoria and market skepticism is wide — and the earnings report will either narrow it or widen it painfully.

Should investors sell immediately? Or is it worth buying CEREBRAS SYSTEMS INC - A?

Wafer-Scale vs. Nvidia — Live Demo Wins the Crowd

At the SuperAI conference in Singapore, Cerebras Chief Strategy Officer Andy Hock held up the company’s monolithic Wafer Scale Engine chip for a crowd of roughly 10,000 attendees. The size comparison with Nvidia’s B200 spoke for itself. In a live test using Meta’s Llama-4 model, the Cerebras system outperformed GPU-based rivals on tasks such as coding a Tetris game and planning travel itineraries — real-time demos designed to drive home the low-latency advantage that everyone from OpenAI to Amazon is paying for.

OpenAI has locked in contracts worth $20 billion with Cerebras, and Amazon Web Services is embedding the chips natively into its infrastructure. The total backlog now stands at $24.6 billion, providing a multi-year revenue cushion.

From $25 Million to $510 Million — But Can Q1 Keep Pace?

Cerebras has posted the kind of growth numbers that usually come from a startup in its early public days. Annual revenue surged from $25 million in 2022 to $510 million in 2025, a 76% jump in the last fiscal year alone. The company also turned profitable on a per-share basis, earning $1.38 per share. Those figures set a high bar for the first quarter of 2026.

The concentration risk is real — a handful of customers account for the bulk of revenue. If any of those relationships show signs of cooling, the stock could take a hit. Strong results, on the other hand, would make the current discount to the consensus target look like an entry opportunity. Either way, June 23 is the moment that will define Cerebras’s early life on the public market.

Ad

CEREBRAS SYSTEMS INC - A Stock: Buy or Sell?! New CEREBRAS SYSTEMS INC - A Analysis from June 19 delivers the answer:

The latest CEREBRAS SYSTEMS INC - A figures speak for themselves: Urgent action needed for CEREBRAS SYSTEMS INC - A investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from June 19.

CEREBRAS SYSTEMS INC - A: Buy or sell? Read more here...

Tags: CEREBRAS SYSTEMS INC - A
SiterGedge

SiterGedge

Related Posts

ServiceNow Stock
AI & Quantum Computing

ServiceNow’s Q1 Revenue Jumps 22% as AI Bet Pays Off, but Armis Price Tag Weighs on Margins

June 19, 2026
SpaceX Stock
Analysis

SpaceX’s $20 Billion Bond Plan and $401 Analyst Target Collide as First Week Rally Fades

June 19, 2026
IBM Stock
AI & Quantum Computing

IBM Navigates an AI Identity Crisis: Consultancy Gains Under Threat as Software Push Accelerates

June 19, 2026
Next Post
Medtronic Stock

Medtronic's Asian Push and Portfolio Reshuffle Fail to Lift Stock from Its Lows

Kuros Biosciences Stock

Kuros Biosciences: Revenue Surges 72% But Shares Sink to 52-Week Low

Core Lithium Stock

Core Lithium's Twin Catalyst: A$290M Funding and Bynoe Acquisition Target 2026 Production

Recommended

Tyler Stock

Institutional Investors Recalibrate Stakes in Government Software Provider

5 months ago
Trinet Stock

Trinet Stock: A Study in Contradictions Amid Steep Decline

10 months ago
Strategy Stock

Conflicting Signals Leave Strategy Investors at a Crossroads

9 months ago
Vulcan Energy Stock

Vulcan Energy Powers Europe’s Lithium Independence Drive

7 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Netflix Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics XRP
No Result
View All Result

Highlights

Kuros Biosciences: Revenue Surges 72% But Shares Sink to 52-Week Low

Medtronic’s Asian Push and Portfolio Reshuffle Fail to Lift Stock from Its Lows

Cerebras Races Into First Earnings Report After Back-to-Back Double-Digit Gains

Outlook Therapeutics’ July 16 Shareholder Vote to Decide Nasdaq Fate as FDA Decision Looms on July 29

XPeng’s X9 Dominates Norwegian Range Test, but European Launch Fails to Ignite Stock

ServiceNow’s Q1 Revenue Jumps 22% as AI Bet Pays Off, but Armis Price Tag Weighs on Margins

Trending

Rocket Lab USA Stock
Industrial

Rocket Lab’s New Phase: Index Entry and Robotics M&A Converge to Reshape the Investment Thesis

by Rodolfo Hanigan
June 19, 2026
0

Monday will bring Rocket Lab a structural shift that no single launch can match. The stock joins...

Vital Farms Stock

Vital Farms Faces Twin Storms: Legal Investigation and Institutional Flight

June 19, 2026
Core Lithium Stock

Core Lithium’s Twin Catalyst: A$290M Funding and Bynoe Acquisition Target 2026 Production

June 19, 2026
Kuros Biosciences Stock

Kuros Biosciences: Revenue Surges 72% But Shares Sink to 52-Week Low

June 19, 2026
Medtronic Stock

Medtronic’s Asian Push and Portfolio Reshuffle Fail to Lift Stock from Its Lows

June 19, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Rocket Lab’s New Phase: Index Entry and Robotics M&A Converge to Reshape the Investment Thesis
  • Vital Farms Faces Twin Storms: Legal Investigation and Institutional Flight
  • Core Lithium’s Twin Catalyst: A$290M Funding and Bynoe Acquisition Target 2026 Production

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com